Clinical trial Recruiting at 1 site Observational Ages 19 and up

Difference in finger, earlobe, and forehead oxygen levels to predict outcomes in dyspnea

Official title: Prognostic Significance of Multi-site Pulse Oximetry Differences in Dyspneic Emergency Department Patients

Run by Yonsei University · NCT07824414 · Data updated 2026-11-12

In adults with breathing trouble, this study tests whether differences in SpO2 readings from different body sites can predict who might have worse outcomes.

Quick facts

Study typeObservational
Ages19 Years and up
SexAll
Enrollment400 (estimated)
SponsorYonsei University
Academic / other
Locations1 site (Seoul, Seoul)
StatusRecruiting
StartedMay 29, 2026
Main results expectedMarch 31, 2027
Study endsApril 30, 2027
Registry record updatedSeptember 17, 2026
Trial IDNCT07824414 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 19 years or older presenting to ED with dyspnea and KTAS levels 1-3.

Probably not a fit

Patients who do not show differences in SpO2 between sites or who do not experience poor outcomes may not derive predictive benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study enrolls adults (≥19) with dyspnea presenting to a single emergency department. SpO2 is measured simultaneously at the finger, earlobe, and forehead, along with perfusion indices, to calculate inter-site differences (ΔSpO2). The primary outcome compares mean ΔSpO2 between patients who experience poor outcomes (death or ICU admission) and those with favorable outcomes. Secondary analyses assess associations with mortality, ICU admission, the need for intubation, lactate, and perfusion index, and compare predictive performance against established early warning scores. Data are collected at presentation and outcomes are obtained from medical records; analyses include logistic regression and ROC methods. The study is led by Yonsei University at Yonsei University Severance Hospital in Seoul, Korea, and focuses on adult dyspnea patients admitted with KTAS levels 1-3.

Why it matters

Potential benefit: If successful, ΔSpO2 measurements could help clinicians identify high-risk dyspnea patients earlier and tailor monitoring and interventions.

How similar studies have gone: This is a prospective approach building on prior interest in multi-site SpO2 differences for prognosis, with ongoing evaluation against early warning scores.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients aged 19 years or older presenting to the emergency department with dyspnea, classified as KTAS level 1-3

Exclusion Criteria:

* Patients in whom SpO₂ measurements were not obtained simultaneously
* Patients in whom arterial blood gas analysis was not ordered at initial evaluation
* Pregnant patients
* Patients with facial trauma or hand trauma
* Patients with amputation, injury, or burns at the measurement sites
* Patients wearing nail polish
* Patients with dyshemoglobinemia
* Non-Korean nationality
* Patients who did not provide consent to participate in the study

Where it's running

  • Yonsei University Severance Hospital
    Seoul, Seoul, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.